MNX internals
| ||||||||||||||||||||||||||||
| Parent-child relations graph |
|
|||||||||||||||||||||||||||
| Identifier | Description |
|---|---|
CHEBI:72965 chebi:72965 ZJVVOYPTFQEGPH-AUTSUKAISA-N | N-tetracosanoylsphingosine C24 Cer Cer(d18:1/24:0) Ceramide (d18:1/24:0) N-(tetracosanoyl)ceramide N-(tetracosanoyl)sphing-4-enine N-[(2S,3R,4E)-1,3-dihydroxyoctadec-4-en-2-yl]tetracosanamide N-lignoceroylsphingosine N-tetracosanoyl-sphing-4-enine N-tetracosanoylsphing-4-enine |
| hmdb:HMDB0004956 ZJVVOYPTFQEGPH-AUTSUKAISA-N | Cer(d18:1/24:0) (2S,3R,4E)-2-Acylaminooctadec-4-ene-1,3-diol (2S,3R,4E)-2-acylamino-1,3-Octadec-4-enediol C24 Cer C24 cer C24-Ceramide C24:0 Ceramide Cer Cer d18:1/24:0 Ceramide Ceramide (d18:1,C24:0) Ceramide (d18:1/24:0) Ceramide 24 Ceramide d18:1/24:0 Ceramide(d18:1/24:0) D-erythro-1,3-Dihydroxy-2-tetracosanoylamido-trans-4-octadecene N-(Tetracosanoyl)-sphing-4-enine N-(Tetracosanoyl)ceramide N-(Tetracosanoyl)sphing-4-enine N-Acylsphingosine N-Lignoceroylsphingosine N-Tetracosanoyl C18-sphingosine N-Tetracosanoylsphing-4-enine N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-octadecanamide N-[(2S,3R,4E)-1,3-dihydroxyoctadec-4-en-2-yl]tetracosanamide |
lipidmaps:LMSP02010012 lipidmapsM:LMSP02010012 ZJVVOYPTFQEGPH-AUTSUKAISA-N | Cer(d18:1/24:0) C24 Cer Cer 42:1 Cer[NS] N-(tetracosanoyl)-ceramide N-(tetracosanoyl)-sphing-4-enine N-lignoceroyl-sphingosine O2 |
SLM:000000634 slm:000000634 ZJVVOYPTFQEGPH-AUTSUKAISA-N | N-(tetracosanoyl)-sphing-4-enine Cer(d18:1(4E)/24:0) Ceramide (d18:1(4E)/24:0) N-tetracosanoylsphingosine |
vmhM:sphgs_tecsa vmhM:sphgs_tecsa vmhmetabolite:sphgs_tecsa vmhmetabolite:sphgs_tecsa ZJVVOYPTFQEGPH-AUTSUKAISA-N | N-tetracosanoylsphingosine (2S,3R,4E)-2-Acylaminooctadec-4-ene-1,3-diol (2S,3R,4E)-2-acylamino-1,3-Octadec-4-enediol C24 Cer C24-Ceramide C24:0 Ceramide Cell signaling agent Cellular membrane Cer Cer d18:1/24:0 Cer(d18:1/24:0) Ceramide Ceramide (d18:1,C24:0) Ceramide (d18:1/24:0) Ceramide 24 Ceramide d18:1/24:0 Ceramide(d18:1/24:0) Chaos Cytoplasma D-erythro-1,3-Dihydroxy-2-tetracosanoylamido-trans-4-octadecene Dietary supplement Digestion Extracellular region Faecal Faeces Fauna Fecal Inflammation agent Inner membrane Insulin resistance Insulin resistance syndrome Kidneys Lipid metabolic process Membrane integrity agent Membrane stability agent Metabolic syndrome x Myelin N-(Tetracosanoyl)-sphing-4-enine N-(Tetracosanoyl)ceramide N-(Tetracosanoyl)sphing-4-enine N-Acylsphingosine N-Lignoceroylsphingosine N-Tetracosanoyl C18-sphingosine N-Tetracosanoylsphing-4-enine N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-octadecanamide Necrotic cell death Necrotic process Neuron Nutraceutical Reaven's syndrome Secondary messenger Signal transduction Signaling agent Signalling molecule Stool Striated muscle Surface-active agent Syndrome x Testes Testis Thrombocyte Type i pcd Type ii pcd |
metacyc.compound:CPD-21994 metacycM:CPD-21994 ZJVVOYPTFQEGPH-AUTSUKAISA-N | ceramide N(24:0)S(18:1) N-tetracosanoylsphingosine sphing-4-enine-24-ceramide |
hmdb:HMDB0000831 hmdb:HMDB00831 hmdb:HMDB04956 vmhM:lgncsphgs_N vmhM:lgncsphgs_N vmhM:M_sphgs_tecsa | secondary/obsolete/fantasy identifier |